288 related articles for article (PubMed ID: 25960230)
21. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors.
Shiri F; Pirhadi S; Ghasemi JB
J Biomol Struct Dyn; 2019 Apr; 37(7):1800-1812. PubMed ID: 29695192
[TBL] [Abstract][Full Text] [Related]
22. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B; Singh N
Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
[TBL] [Abstract][Full Text] [Related]
23. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
Rees TM; Brimijoin S
Drugs Today (Barc); 2003 Jan; 39(1):75-83. PubMed ID: 12669110
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease.
de Almeida JR; Figueiro M; Almeida WP; de Paula da Silva CHT
Future Med Chem; 2018 May; 10(9):1037-1053. PubMed ID: 29676170
[TBL] [Abstract][Full Text] [Related]
25. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
Kuppusamy A; Arumugam M; George S
Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
[TBL] [Abstract][Full Text] [Related]
26. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
29. A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study.
Saravanaraman P; Chinnadurai RK; Boopathy R
J Comput Biol; 2014 Aug; 21(8):632-47. PubMed ID: 24611490
[TBL] [Abstract][Full Text] [Related]
30. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
31. Combined Structure and Ligand-Based Design of Selective Acetylcholinesterase Inhibitors.
Pérez-Sánchez H; den Haan H; Pérez-Garrido A; Peña-García J; Chakraborty S; Erdogan Orhan I; Senol Deniz FS; Villalgordo JM
J Chem Inf Model; 2021 Jan; 61(1):467-480. PubMed ID: 33320652
[TBL] [Abstract][Full Text] [Related]
32. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer's plaque pathology.
Dhanjal JK; Goyal S; Sharma S; Hamid R; Grover A
Biochem Biophys Res Commun; 2014 Jan; 443(3):1054-9. PubMed ID: 24365147
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
[TBL] [Abstract][Full Text] [Related]
35. Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics-Poisson-Boltzmann Surface Area Calculations.
Chennai HY; Belaidi S; Bourougaa L; Ouassaf M; Sinha L; Samadi A; Chtita S
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542869
[TBL] [Abstract][Full Text] [Related]
36. Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.
Bagri K; Kumar A; Manisha ; Kumar P
Mini Rev Med Chem; 2020; 20(14):1403-1435. PubMed ID: 31884928
[TBL] [Abstract][Full Text] [Related]
37. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
38. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.
Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z
Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451
[TBL] [Abstract][Full Text] [Related]
39. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
40. Structure-Based Discovery of Dual-Target Hits for Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptors: In Silico Studies and In Vitro Confirmation.
Oddsson S; Kowal NM; Ahring PK; Olafsdottir ES; Balle T
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]